Table of Content

1. Executive Summary
   1.1. Global Preimplantation Genetic Testing Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global Sectorial Outlook
       2.3.2. Global GDP Growth Outlook
       2.3.3. Global Healthcare Spending Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   3.1. Epidemiology - Disease Prevalence and Incidence
   3.2. Technology Assessment
   3.3. Regulatory Landscape
   3.4. Value Chain Analysis
   3.5. Key Deals and Mergers
   3.6. PESTLE Analysis
   3.7. Porter’s Five Force Analysis
4. Global Preimplantation Genetic Testing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   4.1. Key Highlights
       4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
       4.1.2. Absolute $ Opportunity
   4.2. Market Size (US$ Bn) Analysis and Forecast
       4.2.1. Historical Market Size (US$ Bn) Analysis, 2018-2022
       4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
   4.3. Global Preimplantation Genetic Testing Market Outlook: Test Type
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Bn) Analysis, By Test Type, 2018 - 2022
       4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2023 - 2031
           4.3.3.1. Diagnostics
           4.3.3.2. Screening
   4.4. Market Attractiveness Analysis: Test Type
   4.5. Global Preimplantation Genetic Testing Market Outlook: Technology
       4.5.1. Introduction / Key Findings
       4.5.2. Historical Market Size (US$ Bn) Analysis, By Technology, 2018 - 2022
       4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
           4.5.3.1. CGH-based
           4.5.3.2. FISH-based
           4.5.3.3. NGS-based
           4.5.3.4. SNP-based
           4.5.3.5. PCR-based
   4.6. Market Attractiveness Analysis: Technology
   4.7. Global Preimplantation Genetic Testing Market Outlook: End User
       4.7.1. Introduction / Key Findings
       4.7.2. Historical Market Size (US$ Bn) Analysis, By End User, 2018 - 2022
       4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
           4.7.3.1. Infectious Diseases
           4.7.3.2. Neurological Diseases
           4.7.3.3. Autoimmune Diseases
           4.7.3.4. Oncology
           4.7.3.5. Others
   4.8. Market Attractiveness Analysis: End User
5. Global Preimplantation Genetic Testing Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2018 - 2022
   5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2023 - 2031
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region
6. North America Preimplantation Genetic Testing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   6.1. Key Highlights
   6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
       6.2.1. By Country
       6.2.2. By Test Type
       6.2.3. By Technology
       6.2.4. By End User
   6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       6.3.1. U.S.
       6.3.2. Canada
   6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2023 - 2031
       6.4.1. Diagnostics
       6.4.2. Screening
   6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
       6.5.1. CGH-based
       6.5.2. FISH-based
       6.5.3. NGS-based
       6.5.4. SNP-based
       6.5.5. PCR-based
   6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
       6.6.1. Hospitals
       6.6.2. Diagnostic Labs
       6.6.3. Research & Academic Institutions
       6.6.4. Specialized Clinics
       6.6.5. Others
   6.7. Market Attractiveness Analysis
7. Europe Preimplantation Genetic Testing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   7.1. Key Highlights
   7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
       7.2.1. By Country
       7.2.2. By Test Type
       7.2.3. By Technology
       7.2.4. By End User
   7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       7.3.1. Germany
       7.3.2. France
       7.3.3. U.K.
       7.3.4. Italy
       7.3.5. Spain
       7.3.6. Russia
       7.3.7. Türkiye
       7.3.8. Rest of Europe
   7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2023 - 2031
       7.4.1. Diagnostics
       7.4.2. Screening
   7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
       7.5.1. CGH-based
       7.5.2. FISH-based
       7.5.3. NGS-based
       7.5.4. SNP-based
       7.5.5. PCR-based
   7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
       7.6.1. Hospitals
       7.6.2. Diagnostic Labs
       7.6.3. Research & Academic Institutions
       7.6.4. Specialized Clinics
       7.6.5. Others
   7.7. Market Attractiveness Analysis
8. East Asia Preimplantation Genetic Testing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   8.1. Key Highlights
   8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
       8.2.1. By Country
       8.2.2. By Test Type
       8.2.3. By Technology
       8.2.4. By End User
   8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       8.3.1. China
       8.3.2. Japan
       8.3.3. South Korea
   8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2023 - 2031
       8.4.1. Diagnostics
       8.4.2. Screening
   8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
       8.5.1. CGH-based
       8.5.2. FISH-based
       8.5.3. NGS-based
       8.5.4. SNP-based
       8.5.5. PCR-based
   8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
       8.6.1. Hospitals
       8.6.2. Diagnostic Labs
       8.6.3. Research & Academic Institutions
       8.6.4. Specialized Clinics
       8.6.5. Others
   8.7. Market Attractiveness Analysis
9. South Asia & Oceania Preimplantation Genetic Testing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   9.1. Key Highlights
   9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
       9.2.1. By Country
       9.2.2. By Test Type
       9.2.3. By Technology
       9.2.4. By End User
   9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       9.3.1. India
       9.3.2. Southeast Asia
       9.3.3. ANZ
       9.3.4. Rest of South Asia & Oceania
   9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2023 - 2031
       9.4.1. Diagnostics
       9.4.2. Screening
   9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
       9.5.1. CGH-based
       9.5.2. FISH-based
       9.5.3. NGS-based
       9.5.4. SNP-based
       9.5.5. PCR-based
   9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
       9.6.1. Hospitals
       9.6.2. Diagnostic Labs
       9.6.3. Research & Academic Institutions
       9.6.4. Specialized Clinics
       9.6.5. Others
   9.7. Market Attractiveness Analysis
10. Latin America Preimplantation Genetic Testing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   10.1. Key Highlights
   10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
       10.2.1. By Country
       10.2.2. By Test Type
       10.2.3. By Technology
       10.2.4. By End User
   10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       10.3.1. Brazil
       10.3.2. Mexico
       10.3.3. Rest of Latin America
   10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2023 - 2031
       10.4.1. Diagnostics
       10.4.2. Screening
   10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
       10.5.1. CGH-based
       10.5.2. FISH-based
       10.5.3. NGS-based
       10.5.4. SNP-based
       10.5.5. PCR-based
   10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
       10.6.1. Hospitals
       10.6.2. Diagnostic Labs
       10.6.3. Research & Academic Institutions
       10.6.4. Specialized Clinics
       10.6.5. Others
   10.7. Market Attractiveness Analysis
11. Middle East & Africa Preimplantation Genetic Testing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   11.1. Key Highlights
   11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
       11.2.1. By Country
       11.2.2. By Test Type
       11.2.3. By Technology
       11.2.4. By End User
   11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       11.3.1. GCC Countries
       11.3.2. Egypt
       11.3.3. South Africa
       11.3.4. Northern Africa
       11.3.5. Rest of Middle East & Africa
   11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2023 - 2031
       11.4.1. Diagnostics
       11.4.2. Screening
   11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
       11.5.1. CGH-based
       11.5.2. FISH-based
       11.5.3. NGS-based
       11.5.4. SNP-based
       11.5.5. PCR-based
   11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
       11.6.1. Hospitals
       11.6.2. Diagnostic Labs
       11.6.3. Research & Academic Institutions
       11.6.4. Specialized Clinics
       11.6.5. Others
   11.7. Market Attractiveness Analysis
12. Competition Landscape
   12.1. Market Share Analysis, 2023
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping by Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       12.3.1. Agilent Technologies Inc.
           12.3.1.1. Overview
           12.3.1.2. Segments and Products
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. Abbott Laboratories
       12.3.3. CooperSurgical Inc.
       12.3.4. Oxford Gene Technology IP
       12.3.5. Illumina Inc.
       12.3.6. Thermo Fisher Scientific Inc.
       12.3.7. PerkinElmer Inc.
       12.3.8. Genea Limited
       12.3.9. Natera Inc.
       12.3.10. Rubicon Genomics Inc.
       12.3.11. CombiMatrix Corporation
13. Appendix
   13.1. Research Methodology
   13.2. Research Assumptions
   13.3. Acronyms and Abbreviations